Statistics for Renalytix AI (id:3923 RENX)
Valuation metrics
Market cap
25.86M
Enterprise value
13.11M
Trailing P/E (ttm)
-30.65
Forward P/E
3.00
PEG ratio
3.00
Price/Sales (ttm)
11.30
Price/Book (mrq)
-113.12
Enterprise Value/Revenue
7.30
Enterprise Value/EBITDA
3.00
Overview
Shares outstanding
333.64M
Float
123.37M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
290.79K
Average volume (90 days)
Price summary
52-Week low
6.50
52-Week high
74.90
52-Week change
-89.47%
Beta
2.07
50-Day moving average
7.69
200-Day moving average
16.94
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
June 30, 2024
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
6.82%
Operating margin
-942.83%
Operational effectiveness
Return on assets
-93.54%
Return on equity
425.97%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
156.00K
EBITDA
-22,444,874.00
Net income to common (ttm)
-26,236,529.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
3.67M
Total cash per share (mrq)
5.00
Total debt (mrq)
6.69M
Total Debt/Equity (mrq)
3.00
Current ratio (mrq)
53.20%
Book value per share (mrq)
5.00
Cash flow
Cash flow statement
-23,613,347.00
Levered free cash flow (LFCF)
-15,271,018.00